Remove Cancer Remove New York Remove Test
article thumbnail

These 10 biotech companies are changing how we discover new drugs and treat complex diseases

Fast Company Tech

AlzPaths highly sensitive blood test can detect signs of Alzheimers disease before symptoms developand in time to potentially benefit from new treatments. 10x Genomics and Syncell streamline cutting-edge analytics for life science research, while Nabla Bio is using generative AI to design completely new antibodies.

article thumbnail

C2i, a genomics SaaS product to detect traces of cancer, raises $100M Series B

TechCrunch

If you or a loved one has ever undergone a tumor removal as part of cancer treatment, you’re likely familiar with the period of uncertainty and fear that follows. Will the cancer return, and if so, will the doctors catch it at an early enough stage? The biggest question in cancer treatment is, ‘Is it working?’

Cancer 95
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Isabl’s rapid whole-genome analysis opens the playbook for cancer treatment

TechCrunch

Every cancer is unique because every person is unique, and one of the most important weapons in any cancer battle is information. Isabl offers that in abundance through rapid sequencing of cancer cells’ entire genomes, potentially showing which therapies will and won’t be effective within days.

Cancer 85
article thumbnail

From improving cancer treatments to saving the bees, these are the companies in IndieBio’s latest class

TechCrunch

Ultra-precise cancer therapies! IndieBio initially operated solely out of San Francisco, with the accelerator expanding just last year to include a New York cohort that runs in parallel. The SF program is led by Managing Director Po Bronson, while the New York program is led by Managing Director Stephen Chambers.

Cancer 104
article thumbnail

Forward Health raises $225M from investors including The Weeknd as it looks to expand nationwide

TechCrunch

markets including LA, New York, Chicago, SF and Washington, D.C., “We’ve got our [in-clinic] body scanners, our blood tests, our gene sequencing – we basically collect on the order of about 500 biometric data points,” Aoun said. Forward, which currently operates clinics in select U.S.

Cancer 141
article thumbnail

8 ways startups are changing the healthcare industry

The Next Web

In 2014 and beyond, consumers will finally start to benefit from some of the innovations that have been evolving over the past year, from 3D prosthetics to cutting-edge genetic testing. Not surprisingly, the patent licensing was cost prohibitive for research and prevented bringing genetic testing to the masses.

Industry 165
article thumbnail

Next-gen skincare, silk without spiders and pollution for lunch: Meet the biotech startups pitching at IndieBio’s Demo Day

TechCrunch

While Gupta remains an adviser, Po Bronson took the role as the new managing director. Bronson was immediately put to the test. This year, the program expanded from operating solely in San Francisco to also create a cohort based in New York. Spintext: CEO Alex Greenhalgh is creating a new, scalable way of making silk.